dromlakhani Against vitamin D supplementation in adults 50-74
STEP 1 — Gather Information
Collect patient age (50-74 years), assess for established indications for vitamin D treatment or testing (e.g., osteoporosis, malabsorption, chronic kidney disease, known vitamin D deficiency, pregnancy), and review current vitamin D intake from diet, supplements, and sun exposure.
STEP 2 — Rule In / Rule Out
If the patient is aged 50-74 years and has no established indications for vitamin D treatment or testing, proceed; otherwise, manage according to the specific indication (e.g., treat deficiency, osteoporosis) and do not follow this recommendation.
STEP 3 — Classify or Stratify
Determine whether the patient is currently taking vitamin D supplements exceeding the Dietary Reference Intake (DRI) (600 IU daily for ages 50-70, 800 IU daily for >70 years) or considering initiation of such supplementation.
STEP 4 — Decide
Advise against routine vitamin D supplementation beyond the DRI; recommend obtaining vitamin D through diet and safe sun exposure to meet DRI, and discourage prescribing supplemental vitamin D above DRI for disease prevention in this group.
Clinical Guardrails / Mimics / Pitfalls
Do not apply to patients with indications for vitamin D (e.g., osteoporosis, malabsorption, CKD, known deficiency); avoid high-dose intermittent regimens; do not rely on serum 25(OH)D testing to guide supplementation in generally healthy adults 50-74; do not extrapolate to those <50 or ≥75 years without separate assessment.
Concrete Clinical Example
A 62-year-old man with no bone disease, normal diet, and limited sun exposure asks whether he should take a vitamin D supplement; advise against routine supplementation beyond DRI, encourage dietary sources and safe sun exposure to meet the RDA of 600 IU daily.
Source: Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290